Date: Tuesday 16th March 2021 Time: 14:00-15:00 GMT Speakers: Eloisa Brook (GSK), Joanna Moore (GSK), and George Birkbeck (GSK).
Who is this event intended for? Statisticians supporting in-vivo studies. What is the benefit of attending? Hear about how GSK has evaluated home cage monitoring systems, sharing information on how the systems work as well as giving an idea what the input and impact has been from the statistical analyses carried out.
Typically, animal welfare and behaviour are monitored and assessed visually at periodic times throughout the day. However, in order to go beyond this level of assessment we have been using the Digital Ventilated Cage (DVC®) to capture this information quantitively. The DVC® is a non-invasive Home Cage Monitoring system that uses electromagnetic sensors to track and monitor the cage activity.
Research Statistics advised on study designs, protocols and carried out extensive exploratory and further statistical analyses on the data. This webinar will give an overview of the system and the data collected, along with the benefits gained from continuous cage monitoring using the DVC®. We will use a case study to highlight some of the key discussion points in this presentation.
All animal studies were ethically reviewed and carried out in accordance with Animals (Scientific Procedures) Act 1986 and the GSK Policy on the Care, Welfare and Treatment of Animal.
You can now register for this event.
This event is free of charge to Members and Non-Members of PSI.
To register for the session, please click here.
Eloisa is a Statistical leader at GSK, she has worked extensively for the last 5 years with in-vivo groups at GSK and is a key partner of the protocol review forums for animal studies. She has a particular interest in animal welfare.
Joanna has worked with laboratory animals for over 25 years, in a range of roles across different sectors, she has always had a strong focus on welfare and enrichment, in 2018 she was awarded a PhD in Animal Sciences and more recently, she has recently completed an assessment of the mouse DVC to demonstrate the capabilities of this system in terms of what it can teach us to understand the needs of the mouse.
George has recently joined GSK, having completed his MSc in Statistics which included analysing DVC data for his dissertation. Since joining GSK, George has been interested in learning about home cage monitoring and how this has the potential of improving the well-being of mice in the pre-clinical setting.
PSI VisSIG Wonderful Wednesdays
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The field of data visualization is the intersection of data journalism, statistics, graphic design, computer science, neuroscience, and cognitive psychology. We will focus on the latter two fields of data visualization as it relates to data visualization: neuroscience and cognitive psychology.
PSI One-Day Meeting: Missing Data in Clinical Trials - Past, Present and Future
At this meeting we will present the evolution of missing data approaches, looking at how they have been handled in the past, the current established missing data approaches and the impact of the new ICH E9 R1 addendum on the handling of missing data, focussing in particular on the treatment policy estimand.
R is quickly gaining popularity within the pharmaceutical industry due to it being a very powerful object-orientated language, and is able to produce analyses and high quality graphics. This will be a hands-on interactive course and will utilise the RStudio Cloud development environment.
As a statistician in the Biostatistics and Programming Department, you will be responsible for the methodological and statistical aspects of projects in early clinical development in order to optimize the early development plan and ensure its coherence.
As a Director of Statistics, you will be accountable for guiding statisticians in their work, performing senior review of documentation and output deliveries, providing oversight and advising on best practices approach to statistics for clinical trials.